# Bristol-Myers Squibb Company (BMY) — Q3-2016 Earnings Results

**Report date:** 2016-10-27 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 5.42%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.77 | N/A | +18.64% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed satisfaction with the earnings beat. They emphasized their commitment to maintaining momentum in their product pipeline.

**Key quotes:**

> The company is pleased with the EPS performance this quarter.

> Management highlighted ongoing efforts to drive growth in key therapeutic areas.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance indicates effective cost management and potentially robust product sales. The stock's 5.42% increase reflects investor confidence following the earnings beat. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2016_